Pharmacy Supply Chain Visibility Crisis Threatens Healthcare Resilience
Event summary
- A Tecsys survey found that only 20% of US healthcare leaders have real-time visibility across pharmacy inventory and care settings.
- 77% of surveyed leaders report being unprepared for major disruptions, with drug shortages cited as the primary cause (79%).
- Data readiness is hindering AI adoption in pharmacy, with only 15% fully deploying AI/ML for key functions.
- A misalignment exists between pharmacy/supply chain leaders (48%) and hospital executives (15%) regarding the strategic value of pharmacy operations.
The big picture
The survey highlights a systemic vulnerability within US healthcare, where a lack of real-time supply chain visibility is hindering operational efficiency and patient care. This crisis, exacerbated by ongoing drug shortages and cost volatility, represents a significant opportunity for technology providers like Tecsys to offer solutions, but also underscores the broader challenges of digital transformation within a complex and highly regulated industry. The misalignment in strategic perception suggests a need for a fundamental shift in how pharmacy is valued and integrated within healthcare systems.
What we're watching
- Adoption Lag
- The slow adoption of AI/ML solutions suggests a deeper issue than just technological capability; data integration and organizational buy-in will be critical for Tecsys to demonstrate value and drive adoption.
- Strategic Alignment
- The disconnect between pharmacy leaders' perception of their strategic role and hospital executives' view will likely constrain investment and innovation within pharmacy departments, potentially limiting the impact of supply chain technology implementations.
- Regulatory Pressure
- Increased regulatory scrutiny surrounding drug shortages and supply chain resilience will likely accelerate the need for improved visibility and risk management, creating both opportunities and pressure for vendors like Tecsys.
Related topics